Marketing Authorization Holders need to fulfil their responsibilities to perform regular risk-based audit(s) of their pharmacovigilance system (i.e. auditing of their affiliates and partners). In addition, vendor qualification audits need to be conducted on demand.
Our Pharmacovigilance audits obtain evidence and evaluate the evidence objectively to determine the extent to which the audit criteria are fulfilled and contribute to corrective and preventative actions (CAPA) ensure the improvement of risk management, control, and governance processes.
We apply our broad and long-term experience, as well as global network to fulfil the requested support regarding the planning Pharmacovigilance audits at various levels (strategic, tactical, and operational).
- Support for defining and implementing risk-based audit strategy / process
- PV System / Process gap analysis and pre-inspection support
- Conduct PV audits on behalf of the company:
- System audits at headquarter level
- Affiliate audits
- License partner and distributor audits
- Vendor and service provider audits
- Process and document audits (g. Pharmacovigilance System Master File (PSMF), Risk Management Plan (RMP), Periodic Safety Update Report (PSUR), QPPV Oversight)
- Prepare of audit plans, conduct of the audits and provision of detailed audit reports
- Provide flexible allocation of auditors based on annual audit program and risk-based audit strategy according to GVP requirements
- Ensure adherence to the annual audit program
- Conduct ad-hoc and triggered audits upon request
- Perform compliance monitoring and reporting to QPPV and QA department regarding timely CAPA implementation and audit results
- Support for implementation of company procedure(s) on auditing and CAPA management
- Support for follow-up activities of audits or Health Authorities inspections, i.e. the management of corrective and preventive actions (CAPAs)
PharmaLex offers customized Pharmacovigilance Auditing service based on audit scope and complexity:
What our clients say
I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.
Medical Team Leader, Multi Tumor Franchise Roche Products Ltd
PharmaLex is dedicated to delivering a comprehensive portfolio while their modular approach allows tailor-made solutions. They acknowledge our feedback, modify their approach and adapt accordingly.